Author

J. McKeating

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Vaughan-Jackson· 1 shared H. Ohashi· 1 shared K. Aihara· 1 shared K. Ejima· 1 shared K. Kuramochi· 1 shared K. Maenaka· 1 shared K. Nishioka· 1 shared K. S. Kim· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Vaughan-Jackson

Author profile →

2 papers

Recent·Most cited

Hypoxia dampens innate immune signalling at early time points and increases Zika virus replication in iPSC-derived macrophages

M. Schilling, A. Vaughan-Jackson, W. James, J. McKeating

This study shows that hypoxia reduces interferon-stimulated gene expression and increases Zika virus replication in iPSC-derived macrophages.

bioRxiv · Feb 21, 2023 · PreprintMicrobiology

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

H. Ohashi, K. Watashi, W. Saso, K. Shionoya, S. Iwanami, T. Hirokawa, T. Shirai, S. Kanaya, Y. Ito, K. S. Kim, K. Nishioka, S. Ando, K. Ejima, Y. Koizumi, T. Tanaka, , T. Wakita

This study identifies a new multidrug combination treatment for COVID-19 using nelfinavir and cepharanthine, showing synergistic antiviral effects and improved disease control.

bioRxiv · Apr 14, 2020 · PreprintMicrobiology